Tamula, Richelle Mae S.

HRN: 24-79-68  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/10/2024
CEFUROXIME 1.5GM (VIAL)
04/10/2024
04/17/2024
IV
1200 Mg
Q8
T/C Acute Surgical Abdomen
Waiting Final Action 
04/10/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
04/10/2024
04/17/2024
IV
400 Mg
Q8
T/C Acute Surgical Abdomen
Waiting Final Action 
04/11/2024
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
04/11/2024
04/17/2024
IVTT
1.8g
Q6
PID, UTI
Waiting Final Action 
04/11/2024
GENTAMICIN 40MG/ML, 2ML (AMP)
04/11/2024
04/17/2024
IVTT
72mg
Q8
PID, UTI
Waiting Final Action 
04/11/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
04/11/2024
04/17/2024
IVTT
270mg
Q6
PID, UTI
Waiting Final Action 
04/13/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
04/13/2024
04/30/2024
IVT
4.5g
Q12
S/P ExLap
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: